Table 5.
Baseline Corresponding Plasma Biomarker | 6-Months Follow up Corresponding Plasma Biomarker | |||||||
---|---|---|---|---|---|---|---|---|
Control | Intervention | Control Intervention | Intervention Self-Sustained Phase | |||||
Nutrients (from FFQ) | p-Value | p-Value | p-Value | p-Value | ||||
SFA | 0.137 | 0.524 | 0.178 | 0.406 | −0.038 | 0.874 | 0.295 | 0.194 |
Lauric fatty acid | −0.094 | 0.662 | 0.227 | 0.286 | −0.191 | 0.420 | −0.054 | 0.818 |
Myristic fatty acid | −0.123 | 0.566 | 0.166 | 0.439 | −0.315 | 0.177 | 0.184 | 0.425 |
Palmitic fatty acid | −0.096 | 0.654 | 0.133 | 0.537 | 0.177 | 0.455 | 0.570 | 0.007 |
Stearic fatty acid | 0.020 | 0.925 | −0.072 | 0.738 | 0.387 | 0.092 | −0.128 | 0.581 |
Palmitoleic acid | −0.039 | 0.857 | 0.018 | 0.935 | −0.614 | 0.004 | 0.226 | 0.324 |
MUFA | 0.079 | 0.715 | 0.152 | 0.477 | −0.295 | 0.206 | 0.262 | 0.251 |
Oleic acid | −0.165 | 0.441 | −0.357 | 0.087 | 0.062 | 0.795 | 0.021 | 0.928 |
PUFA | −0.260 | 0.220 | −0.059 | 0.785 | 0.134 | 0.573 | −0.316 | 0.163 |
Linoleic acid | −0.191 | 0.373 | 0.210 | 0.324 | 0.127 | 0.593 | −0.090 | 0.699 |
Alfa-Linolenic acid | 0.217 | 0.307 | 0.302 | 0.152 | 0.073 | 0.760 | −0.083 | 0.722 |
Omega-3 fatty acids | 0.624 | 0.001 | 0.381 | 0.066 | 0.741 | <0.001 | 0.396 | 0.075 |
Eicosapentaenoic fatty acid (EPA) | 0.466 | 0.022 | 0.441 | 0.031 | 0.688 | <0.001 | 0.621 | 0.003 |
Docosahexahenoico (DHA) | 0.673 | <0.001 | 0.347 | 0.097 | 0.775 | <0.001 | 0.292 | 0.198 |
Total Trans fatty acid | 0.080 | 0.711 | −0.033 | 0.878 | −0.081 | 0.733 | −0.059 | 0.800 |
Conjugated linoleic acid | −0.148 | 0.490 | 0.122 | 0.570 | −0.066 | 0.783 | 0.726 | <0.001 |
SFA: Saturated Fatty Acids; MUFA: Monounsaturated fatty acids; PUFA: polyunsaturated fatty acids.